- In November 2023, BD introduced PIVO Pro, a needle-free blood draw device compatible with integrated and long peripheral IV catheters, including the Nexiva Closed IV Catheter System. This innovation aims to enhance patient comfort by reducing needlesticks and improving clinical outcomes, aligning with BD's vision of a "One-Stick Hospital Stay"
- In October 2023, B. Braun expanded its Peripheral Advantage Program to address health inequities in vascular access. This initiative focuses on empowering healthcare providers and improving patient experiences with intravenous therapies, advocating for enhanced standards of care
- In April 2023, BD launched the BD Prevue II System, an advanced ultrasound device equipped with a specialized probe and real-time needle depth markers. Designed to optimize IV placement, this system provides high-quality ultrasound images of needle trajectories, aiming to improve first-attempt success rates in IV insertions
- In March 2022, Shockwave Medical Inc. announced that its Shockwave M5+ peripheral IVL catheter, having received FDA approval and CE Mark, is now commercially available worldwide. The M5+ catheter is designed to enhance IVL treatments by offering additional access options and extending therapy to patients with larger vessel diameters
- In July 2022, B. Braun introduced the Introcan Safety 2 IV Catheter, featuring one-time blood control technology. This innovation aims to increase safety for clinicians by reducing the risk of blood exposure and needlestick injuries during IV access procedures
